Jennifer L. McKimm‐Breschkin

University of Melbourne — Australia

Medicine · Health Sciences

43h-index8.2kcitations113works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(68), Respiratory viral infections research(42), Monoclonal and Polyclonal Antibodies Research(31), Virology and Viral Diseases(15), RNA and protein synthesis mechanisms(10)

Publications113 total

A new concept in antiviral drug design yields a potent influenza inhibitor
2022Open Access
COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference
Antiviral Research·2021· 27 citedOpen Access
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group
Antiviral Research·2021· 39 citedOpen Access
Substitutions at H134 and in the 430-loop region in influenza B neuraminidases can confer reduced susceptibility to multiple neuraminidase inhibitors
Antiviral Research·2020· 2 cited
A clinical trial lacking a control group
International Journal of Infectious Diseases·2019Open Access
Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant
Antiviral Research·2019· 9 cited
Influenza Virus Neuraminidase Structure and Functions
Frontiers in Microbiology·2019· 445 citedOpen Access
Structure of an Influenza A virus N9 neuraminidase with a tetrabrachion-domain stalk
Acta Crystallographica Section F Structural Biology Communications·2019· 22 citedOpen Access
INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) RECOMBINANT HEAD DOMAIN
2018
INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) APO FORM
2018
Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility
Antiviral Research·2018· 13 cited
Structural and Functional Analysis of Anti-Influenza Activity of 4-, 7-, 8- and 9-Deoxygenated 2,3-Difluoro-<i>N</i>-acetylneuraminic Acid Derivatives
Journal of Medicinal Chemistry·2018· 13 citedOpen Access
Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference
Antiviral Research·2017· 74 citedOpen Access
INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 9-DEOXYGENATED 2,3-DIFLUORO-N-ACETYLNEURAMINIC ACID
2017
INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 8-DEOXYGENATED 2,3-DIFLUORO-N-ACETYLNEURAMINIC ACID
2017
INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 7-DEOXYGENATED 2,3-DIFLUORO-N-ACETYLNEURAMINIC ACID
2017
INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 4-DEOXYGENATED 2,3-DIFLUORO-N-ACETYLNEURAMINIC ACID
2017
Mouse Saliva Inhibits Transit of Influenza Virus to the Lower Respiratory Tract by Efficiently Blocking Influenza Virus Neuraminidase Activity
Journal of Virology·2017· 16 citedOpen Access
Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses
Antiviral Research·2016· 51 citedOpen Access
Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN)
Antiviral Research·2015· 21 cited
page 1 of 6Next →

Frequent Co-authors

Peter M. Colman(8), Tony Blick(7), Joseph Varghese(6), Masato Tashiro(6), Frederick G. Hayden(6), Anjali Sahasrabudhe(6), Susan Barrett(6), Maria Zambon(5), Peter G. Mohr(5), Alan Hampson(4), Alan Hay(4), Alexander Klimov(4), Robert G. Webster(4), Victor A. Streltsov(4), Mandy McDonald(4), Graham Hart(4), Catherine A. Macken(3), Michael C. Lawrence(3), Richard C. Bethell(3), Simon P. Tucker(3)